New understanding of biomarkers could lead to earlier diagnosis of fatal diseases

A new research paper sheds light on the way antibodies distinguish between different but closely related 'biomarkers' - proteins which reveal information about the condition of the human body. This new understanding could enable pharmaceutical companies to develop new technologies for quickly diagnosing and treating fatal diseases.

Read the whole article on Physorg

More from Physorg